As the leadership vacuum at the top of the FDA looks poised to close with President Donald Trump’s nominee pick for a replacement commissioner, the agency is reportedly weighing whether to add two | As the leadership vacuum at the top of the FDA looks poised to close with President Donald Trump’s nominee pick for a replacement commissioner, the agency is reportedly weighing whether to add two new deputy posts under that role.

HHS plans to name two deputy commissioners for technology and drugs, said two sources familiar with the matter.

One role would cover technology and artificial intelligence; the other would oversee drugs. No final decisions have been made